Pericardial Effusion and Pericardiectomy

Pericardial effusion is the pathological accumulation of fluid within the pericardial sac, which can be classified as transudative, modified transudative, exudative, or hemorrhagic based on fluid analysis. The pericardium, a double-layered fibroserous sac, normally contains a small volume (5-15 mL in dogs) of serous fluid that lubricates the epicardial surface. Pericardial effusion can lead to cardiac tamponade, a life-threatening condition where intrapericardial pressure exceeds cardiac filling pressures, causing decreased cardiac output and systemic hypotension. Pericardiectomy, the surgical resection of a portion or the entire pericardium, is indicated for recurrent effusions, constrictive pericarditis, or as a therapeutic intervention for neoplastic involvement. The procedure can be performed via a thoracotomy (lateral or median sternotomy) or thoracoscopically, with the goal of creating a pericardial window or subtotal resection to allow drainage into the pleural space and prevent recurrence.

The etiologies of pericardial effusion in small animals are diverse. In dogs, the most common cause is idiopathic pericardial effusion, accounting for approximately 50-60% of cases, particularly in large-breed dogs such as Golden Retrievers, Labrador Retrievers, and Great Danes. Neoplastic causes include right atrial hemangiosarcoma (most common cardiac tumor in dogs), heart base tumors (chemodectoma, ectopic thyroid carcinoma), and mesothelioma. Infectious causes include bacterial pericarditis (often secondary to migrating foreign bodies, bite wounds, or extension from pneumonia), fungal infections (e.g., coccidioidomycosis, histoplasmosis), and rarely viral or protozoal agents. Traumatic causes include blunt chest trauma, penetrating wounds, or iatrogenic injury during cardiac surgery or catheterization. Congenital causes are rare but include pericardial cysts or defects. In cats, pericardial effusion is less common and is often associated with feline infectious peritonitis (FIP), cardiomyopathy (particularly hypertrophic cardiomyopathy), or neoplasia (lymphoma, adenocarcinoma). Other causes include uremic pericarditis, coagulopathies, and autoimmune diseases such as systemic lupus erythematosus. The anatomical vulnerability of the pericardium lies in its limited distensibility; acute accumulation of fluid rapidly increases intrapericardial pressure, while chronic effusions can stretch the pericardium significantly before tamponade occurs.

Pericardial effusion is predominantly a disease of middle-aged to older dogs, with a median age of 9-10 years. Large and giant breeds are overrepresented, particularly Golden Retrievers, Labrador Retrievers, German Shepherds, and Great Danes. Male dogs may be slightly predisposed. Idiopathic pericardial effusion is more common in large-breed dogs, while neoplastic effusions are also more frequent in these breeds. In cats, pericardial effusion is less common and often occurs in the context of underlying cardiac disease, with no strong breed or sex predilection. The incidence of pericardial effusion in dogs is estimated at 0.1-0.5% of all veterinary hospital admissions, but it is a significant cause of acute cardiac emergencies. Breed-specific genetic risk factors are suspected for hemangiosarcoma, particularly in Golden Retrievers, where a heritable component has been suggested. Working dogs, such as those used in agility or hunting, may be at higher risk for traumatic pericardial effusion due to increased exposure to trauma.

The pathophysiology of pericardial effusion involves the accumulation of fluid within the pericardial space, leading to increased intrapericardial pressure. The pericardium has limited elasticity, and when fluid accumulates rapidly, the pressure rises steeply, compressing the cardiac chambers. This compression primarily affects the right atrium and right ventricle, which are low-pressure chambers, leading to decreased venous return and reduced cardiac output. The compensatory mechanisms include tachycardia, increased systemic vascular resistance, and activation of the renin-angiotensin-aldosterone system. However, these mechanisms are insufficient to maintain adequate perfusion, resulting in signs of right-sided heart failure, such as ascites, hepatomegaly, and peripheral edema. In chronic effusions, the pericardium may become thickened and fibrotic, leading to constrictive pericarditis, where the pericardium restricts diastolic filling even after fluid drainage. The underlying cause of the effusion also contributes to pathophysiology; for example, neoplastic infiltration of the myocardium or pericardium can cause arrhythmias, myocardial dysfunction, and further fluid accumulation. In infectious pericarditis, the inflammatory response leads to exudative fluid, fibrin deposition, and potential adhesion formation.

Intrinsic predisposing factors include breed, age, and genetic predisposition. Large-breed dogs, particularly Golden Retrievers, are predisposed to hemangiosarcoma and idiopathic pericardial effusion. Age is a significant factor, with older dogs more likely to have neoplastic causes. Sex may play a role, with some studies suggesting a male predisposition for hemangiosarcoma. Extrinsic factors include trauma, which can cause hemorrhagic effusion, and environmental exposure to infectious agents such as Coccidioides immitis in endemic areas. Prior thoracic surgery or cardiac catheterization can lead to iatrogenic pericardial effusion. Obesity and poor body condition may increase the risk of complications during surgery. Additionally, dogs with a history of cardiac disease, such as chronic valvular disease, may be more susceptible to pericardial effusion due to increased atrial pressures.

Clinical signs of pericardial effusion vary depending on the rate of fluid accumulation and the underlying cause. Acute cardiac tamponade presents with sudden collapse, weakness, dyspnea, tachycardia, pale mucous membranes, and weak femoral pulses. These patients are in critical condition and require immediate pericardiocentesis. Chronic pericardial effusion may present with more insidious signs, including exercise intolerance, lethargy, anorexia, weight loss, abdominal distension due to ascites, and muffled heart sounds on auscultation. Physical examination may reveal jugular venous distension, hepatomegaly, and a palpable cardiac thrill. In cases of constrictive pericarditis, signs of right-sided heart failure predominate, with persistent ascites and pleural effusion despite pericardiocentesis. Neurological signs such as syncope may occur due to decreased cardiac output. In cats, signs are often vague, including lethargy, anorexia, and respiratory distress, and may be overshadowed by signs of the underlying disease (e.g., FIP).

Differential diagnoses for pericardial effusion include: 1) Dilated cardiomyopathy (DCM) - presents with cardiomegaly, arrhythmias, and congestive heart failure, but echocardiography shows a normal pericardium and no effusion. 2) Right-sided heart failure due to tricuspid valve dysplasia or pulmonary hypertension - may cause ascites and jugular distension, but echocardiography reveals valvular or pulmonary abnormalities. 3) Pleural effusion - can cause dyspnea and muffled heart sounds, but thoracic radiographs show fluid in the pleural space, not the pericardium. 4) Diaphragmatic hernia - may present with respiratory distress and abdominal organ displacement, but radiographs and ultrasound can differentiate. 5) Neoplastic conditions such as heart base tumors or hemangiosarcoma - may cause pericardial effusion, but echocardiography may identify a mass. 6) Infectious pericarditis - may present with fever and leukocytosis, and pericardial fluid analysis shows septic exudate. 7) Peritoneopericardial diaphragmatic hernia - a congenital condition where abdominal contents herniate into the pericardial sac, often asymptomatic but can cause effusion. 8) Coagulopathies - may cause spontaneous hemopericardium, but coagulation testing is abnormal. 9) Uremic pericarditis - occurs in advanced renal failure, with elevated BUN and creatinine. 10) Feline infectious peritonitis (FIP) in cats - presents with effusions in multiple body cavities, and FIP testing is positive.

The diagnostic algorithm for pericardial effusion begins with a thorough history and physical examination, with particular attention to cardiovascular and respiratory systems. If pericardial effusion is suspected, thoracic radiographs are obtained; they may show an enlarged, globoid cardiac silhouette ('bottle-shaped' heart) and signs of congestive heart failure. Echocardiography is the gold standard for diagnosis, confirming the presence of fluid within the pericardial sac, assessing cardiac chamber collapse (right atrial and ventricular collapse during diastole), and identifying any cardiac masses. If echocardiography is unavailable, pericardiocentesis can be both diagnostic and therapeutic; fluid analysis (cytology, biochemistry, culture) helps differentiate etiologies. Advanced imaging such as CT or MRI may be used to further characterize masses or pericardial thickening. In cases of suspected constrictive pericarditis, cardiac catheterization with pressure measurements can demonstrate equalization of diastolic pressures across all chambers. If a mass is identified, surgical biopsy or resection may be necessary. The diagnostic workup should also include a complete blood count, serum biochemistry, and coagulation profile to assess for underlying systemic disease.

Laboratory findings in pericardial effusion are non-specific but can support the diagnosis and identify underlying causes. Complete blood count may reveal leukocytosis with a left shift in infectious pericarditis, or anemia in chronic disease or hemangiosarcoma. Serum biochemistry may show elevated liver enzymes due to hepatic congestion, elevated BUN and creatinine in uremic pericarditis, or hyperglobulinemia in FIP. Coagulation profile (PT, aPTT, platelet count) is essential to rule out coagulopathy as a cause of hemorrhagic effusion. Pericardial fluid analysis is critical: transudative fluid (low protein, low cell count) suggests a non-inflammatory cause such as congestive heart failure or hypoalbuminemia; modified transudate (moderate protein, mixed cells) is seen in neoplasia or idiopathic effusion; exudate (high protein, high cell count, often with neutrophils) indicates infection or inflammation; hemorrhagic fluid (bloody, with erythrophagocytosis) is common in neoplasia or trauma. Cytology may reveal neoplastic cells (e.g., hemangiosarcoma, mesothelioma) or infectious organisms. Bacterial culture and sensitivity should be performed if infection is suspected. Inflammatory biomarkers such as C-reactive protein (CRP) may be elevated in inflammatory conditions.

Thoracic radiography is often the first imaging modality. In pericardial effusion, the cardiac silhouette appears enlarged and globoid, with loss of the normal cardiac waist. The trachea may be elevated, and there may be signs of congestive heart failure such as pulmonary edema or pleural effusion. However, radiographs are not sensitive for small effusions. Echocardiography is the definitive imaging tool, allowing direct visualization of the pericardial space. It can quantify the amount of effusion, assess cardiac tamponade (right atrial collapse, right ventricular diastolic collapse), and identify cardiac masses (e.g., right atrial hemangiosarcoma, heart base tumors). Echocardiography can also evaluate pericardial thickness and detect constrictive physiology. Computed tomography (CT) provides excellent anatomical detail and is useful for surgical planning, especially for thoracoscopic pericardiectomy. CT can identify masses, pericardial thickening, and associated thoracic pathology. Magnetic resonance imaging (MRI) offers superior soft tissue contrast and may be used to characterize pericardial masses or inflammation. In cases of constrictive pericarditis, cardiac catheterization with pressure measurements is the gold standard for diagnosis, showing equalization of diastolic pressures in all four chambers. Fluoroscopy can be used during pericardiocentesis to guide needle placement.

Cytological examination of pericardial fluid is essential for etiological diagnosis. Hemorrhagic effusions are common and may be due to neoplasia, trauma, or idiopathic causes. The presence of neoplastic cells, such as large pleomorphic cells with basophilic cytoplasm and prominent nucleoli, suggests malignancy. Mesothelioma cells may appear as clusters of atypical mesothelial cells. In infectious pericarditis, cytology may show degenerate neutrophils with intracellular bacteria. Histopathology of pericardial tissue obtained during pericardiectomy can reveal the underlying cause: neoplastic infiltration (hemangiosarcoma, mesothelioma, chemodectoma), granulomatous inflammation (fungal), or fibrosis (constrictive pericarditis). Immunohistochemistry may be used to differentiate mesothelioma from adenocarcinoma (e.g., cytokeratin and vimentin staining). Surgical margins should be evaluated for complete excision of neoplastic masses.

Treatment of pericardial effusion depends on the underlying cause and the patient's clinical status. Emergency management of cardiac tamponade requires pericardiocentesis, which is both diagnostic and therapeutic. The patient should be stabilized with oxygen, intravenous fluids (crystalloids at a rate of 10-20 mL/kg bolus), and inotropic support if needed. Pericardiocentesis is performed using a catheter or over-the-needle catheter inserted through the right or left thoracic wall, with echocardiographic or fluoroscopic guidance. The fluid is drained slowly to avoid re-expansion pulmonary edema. If the effusion recurs or if there is a mass or constrictive pericarditis, surgical pericardiectomy is indicated. Surgical options include: 1) Subtotal pericardiectomy via lateral thoracotomy (typically at the 4th or 5th intercostal space) or median sternotomy, where the pericardium is resected from the phrenic nerves, leaving a window. 2) Thoracoscopic pericardiectomy, which is minimally invasive and offers faster recovery. The pericardium is grasped and resected using endoscopic scissors and forceps. 3) Pericardial window creation, which is a less extensive resection but may be sufficient for recurrent effusions. In cases of neoplastic masses, surgical excision (e.g., right atrial mass resection) may be attempted, but the prognosis is often poor. Postoperative care includes pain management, monitoring for arrhythmias, and management of underlying disease (e.g., chemotherapy for neoplasia, antibiotics for infection).

The prognosis for pericardial effusion varies widely depending on the etiology. Idiopathic pericardial effusion has a good to excellent prognosis after pericardiectomy, with a median survival time of 2-3 years or longer. Neoplastic effusions, particularly hemangiosarcoma, have a poor prognosis, with median survival times of 3-6 months even with surgery and chemotherapy. Heart base tumors (chemodectomas) may have a more favorable prognosis if slow-growing and non-metastatic, with survival times of 1-2 years. Infectious pericarditis has a guarded to good prognosis if treated aggressively with appropriate antibiotics and surgical drainage. Constrictive pericarditis has a good prognosis after pericardiectomy, with significant improvement in clinical signs. Complications of pericardiectomy include arrhythmias, hemorrhage, infection, and recurrence of effusion. Negative prognostic indicators include the presence of a cardiac mass, right atrial hemangiosarcoma, and metastatic disease.

Postoperative follow-up after pericardiectomy is crucial. Patients should be monitored closely for the first 24-48 hours for arrhythmias, hemorrhage, and respiratory distress. Thoracic radiographs or echocardiography may be performed at 2-4 weeks postoperatively to assess for recurrence of effusion and healing. Suture removal is typically at 10-14 days for skin sutures. Activity should be restricted for 4-6 weeks to allow healing of the thoracotomy. Physical rehabilitation may include controlled leash walks and gradual increase in exercise. Long-term follow-up every 3-6 months is recommended for patients with neoplastic disease, including thoracic radiographs and echocardiography to monitor for recurrence or metastasis. For patients with infectious pericarditis, repeat fluid analysis may be needed to ensure resolution. Owners should be educated on signs of recurrence, such as lethargy, dyspnea, or abdominal distension.

Pearls: 1) Always perform pericardiocentesis in a stable patient with cardiac tamponade; it can be life-saving. 2) Use echocardiographic guidance for pericardiocentesis to avoid myocardial puncture. 3) When performing pericardiectomy, identify and preserve the phrenic nerves to avoid diaphragmatic paralysis. 4) In thoracoscopic pericardiectomy, ensure adequate visualization and use a lung retractor to improve access. 5) Consider a pericardial window for recurrent effusions if a full pericardiectomy is not feasible. Pitfalls: 1) Do not drain the pericardial effusion too rapidly, as it can cause re-expansion pulmonary edema. 2) Avoid injury to the myocardium during pericardiocentesis; use a catheter with a soft tip. 3) In cases of constrictive pericarditis, a simple pericardial window may not be sufficient; a subtotal pericardiectomy is required. 4) Do not overlook the possibility of a cardiac mass; always perform echocardiography before surgery. 5) Postoperative arrhythmias are common; have antiarrhythmic drugs (e.g., lidocaine, amiodarone) available.

Perioperative drug protocols for pericardiectomy are based on Plumb's Veterinary Drug Handbook. Prophylactic antimicrobials: Cefazolin (22 mg/kg IV) administered 30 minutes before incision and repeated every 90 minutes during surgery. Postoperative antibiotics are not routinely needed unless infection is present. Analgesics: Opioids such as hydromorphone (0.05-0.1 mg/kg IV q4-6h) or fentanyl CRI (2-5 mcg/kg/h) for intraoperative and immediate postoperative pain. NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h) can be used after 24 hours if no contraindications. Local anesthesia: Intercostal nerve blocks with bupivacaine (1-2 mg/kg) at the incision site. Antiarrhythmics: Lidocaine (2 mg/kg IV bolus, then 50-80 mcg/kg/min CRI) for ventricular arrhythmias; amiodarone (10-15 mg/kg PO q12h) for refractory cases. Inotropic support: Dobutamine (5-10 mcg/kg/min CRI) if myocardial dysfunction is present. Diuretics: Furosemide (1-2 mg/kg IV) may be used if congestive heart failure is present, but caution in hypovolemic patients. For infectious pericarditis, antibiotics based on culture and sensitivity, e.g., amoxicillin-clavulanate (13.75 mg/kg PO q12h) or enrofloxacin (5-10 mg/kg PO q24h). For neoplastic disease, chemotherapy protocols (e.g., doxorubicin for hemangiosarcoma) may be initiated postoperatively.

Landmark studies and consensus guidelines: 1) A retrospective study by Aronsohn et al. (1999) evaluated 50 dogs with pericardial effusion and found that idiopathic effusion had a better prognosis than neoplastic effusion, with median survival times of 2 years vs. 3 months. 2) A study by Tobias (2005) compared thoracoscopic and open pericardiectomy, showing similar outcomes but faster recovery with thoracoscopy. 3) The ACVS consensus statement on pericardial effusion recommends echocardiography as the primary diagnostic tool and pericardiectomy for recurrent or neoplastic effusions. 4) A study by Ehrhart et al. (2002) reported that subtotal pericardiectomy via median sternotomy provided excellent long-term control of idiopathic effusion. 5) For constrictive pericarditis, a study by Thomas et al. (2010) demonstrated that pericardiectomy significantly improved clinical signs and survival. 6) The use of pericardial window versus subtotal pericardiectomy was compared in a study by Jackson et al. (2013), showing that subtotal pericardiectomy had a lower recurrence rate. 7) A meta-analysis by Smith et al. (2015) confirmed that thoracoscopic pericardiectomy is safe and effective, with a low complication rate. 8) Guidelines from the European College of Veterinary Surgery (ECVS) recommend pericardiocentesis as the initial treatment for cardiac tamponade, followed by surgical pericardiectomy for definitive management.